动物科学与动物医学 |
|
|
|
|
兔支气管败血波氏杆菌外膜囊泡的制备及其蛋白质成分分析 |
南黎1(),黄叶娥2,肖琛闻2,王志鹏2,韦强2,季权安2,李科2,刘燕2(),鲍国连2() |
1.浙江师范大学化学与生命科学学院,浙江 金华 321000 2.浙江省农业科学院畜牧兽医研究所,杭州 310021 |
|
Preparation of outer membrane vesicles from rabbit Bordetella bronchiseptica and their protein composition analysis |
Li NAN1(),Ye’e HUANG2,Chenwen XIAO2,Zhipeng WANG2,Qiang WEI2,Quan’an JI2,Ke LI2,Yan LIU2(),Guolian BAO2() |
1.College of Chemistry and Life Sciences, Zhejiang Normal University, Jinhua 321000, Zhejiang, China 2.Institute of Animal Husbandry and Veterinary Medicine, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China |
引用本文:
南黎,黄叶娥,肖琛闻,王志鹏,韦强,季权安,李科,刘燕,鲍国连. 兔支气管败血波氏杆菌外膜囊泡的制备及其蛋白质成分分析[J]. 浙江大学学报(农业与生命科学版), 2021, 47(2): 251-260.
Li NAN,Ye’e HUANG,Chenwen XIAO,Zhipeng WANG,Qiang WEI,Quan’an JI,Ke LI,Yan LIU,Guolian BAO. Preparation of outer membrane vesicles from rabbit Bordetella bronchiseptica and their protein composition analysis. Journal of Zhejiang University (Agriculture and Life Sciences), 2021, 47(2): 251-260.
链接本文:
http://www.zjujournals.com/agr/CN/10.3785/j.issn.1008-9209.2020.05.190
或
http://www.zjujournals.com/agr/CN/Y2021/V47/I2/251
|
1 |
CHAMBERS J K, MATSUMOTO I, SHIBAHARA T, et al. An outbreak of fatal Bordetella bronchiseptica bronchopneumonia in puppies. Journal of Comparative Pathology, 2019,167:41-45. DOI:10.1016/j.jcpa.2018.12.002
doi: 10.1016/j.jcpa.2018.12.002
|
2 |
YACOUB A T, KATAYAMA M, TRAN J, et al. Bordetella Bronchiseptica in the immunosuppressed population: a case series and review. Mediterranean Journal of Hematology and Infectious Diseases, 2014,6(1):e2014031. DOI:10.4084/MJHID.2014.031
doi: 10.4084/MJHID.2014.031
|
3 |
ELLIS J A. How well do vaccines for Bordetella bronchiseptica work in dogs?A critical review of the literature1977—2014. The Veterinary Journal, 2015,204(1):5-16. DOI:10.1016/j.tvjl.2015.02.006
doi: 10.1016/j.tvjl.2015.02.006
|
4 |
ROIER S, ZINGL F G, CAKAR F, et al. Bacterial outer membrane vesicle biogenesis: a new mechanism and its implications. Microbial Cell, 2016,3(6):257-259. DOI:10.15698/mic2016.06.508
doi: 10.15698/mic2016.06.508
|
5 |
ADRIANI R, MOUSAVI G S L, NAZARIAN S, et al. Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions. Vaccine, 2018,36(2):322-330. DOI:10.1016/j.vaccine.2017.09.00
doi: 10.1016/j.vaccine.2017.09.00
|
6 |
FERNANDEZ-ROJAS M A, VACA S, REYES-LOPEZ M, et al. Outer membrane vesicles of Pasteurella multocida contain virulence factors. Microbiology Open, 2014,3(5):711-717. DOI:10.1002/mbo3.201
doi: 10.1002/mbo3.201
|
7 |
BERLEMAN J E, ALLEN S, DANIELEWICZ M A, et al. The lethal cargo of Myxococcus xanthus outer membrane vesicles. Frontiers in Microbiology, 2014,5:474. DOI:10.3389/fmicb.2014.00474
doi: 10.3389/fmicb.2014.00474
|
8 |
FLEETWOOD A J, LEE M K S, SINGLETON W, et al. Metabolic remodeling, inflammasome activation, and pyroptosis in macrophages stimulated by Porphyromonas gingivalis and its outer membrane vesicles. Frontiers in Celluar and Infection Microbiology, 2017,7:351. DOI:10.3389/fcimb.2017.00351
doi: 10.3389/fcimb.2017.00351
|
9 |
ZARIRI A, BESKERS J, DE WATERBEEMD B VAN, et al. Meningococcal outer membrane vesicle composition-dependent activation of the innate immune response. Infection and Immunity, 2016,84(10):3024-3033. DOI:10.1128/IAI.00635-16
doi: 10.1128/IAI.00635-16
|
10 |
CAI W, KESAVAN D K,WAN J, et al. Bacterial outer membrane vesicles, a potential vaccine candidate in interactions with host cells based. Diagnostic Pathology, 2018,13(1):95. DOI:10.1186/s13000-018-0768-y
doi: 10.1186/s13000-018-0768-y
|
11 |
LEITNER D R, LICHTENEGGER S, TEMEL P, et al. A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles. Frontiers in Microbiology, 2015,6:823. DOI:10.3389/fmicb.2015.00823
doi: 10.3389/fmicb.2015.00823
|
12 |
ACEVEDO R, FERNáNDEZ S, ZAYAS C, et al. Bacterial outer membrane vesicles and vaccine applications. Frontiers in Immunology, 2014,5:121. DOI:10.3389/fimmu.2014.00121
doi: 10.3389/fimmu.2014.00121
|
13 |
ROSENTHAL J A, CHEN L, BAKER J L, et al. Pathogen like particles: biomimetic vaccine carriers engineered at the nanoscale. Current Opinion in Biotechnology, 2014,28(8):51-58. DOI:10.1016/j.copbio.2013.11.005
doi: 10.1016/j.copbio.2013.11.005
|
14 |
ROIER S, FENNINGER J C, LEITNER D R, et al. Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles. International Journal of Medical Microbiology, 2013,303(5):247-256. DOI:10.1016/j.ijmm.2013.05.001
doi: 10.1016/j.ijmm.2013.05.001
|
15 |
ROIER S, LEITNER D R, IWASHKIW J, et al. Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice. PLoS ONE, 2012,7(8):e42664. DOI:10.1371/journal.pone.0042664
doi: 10.1371/journal.pone.0042664
|
16 |
KLIMENTOVá J, STULíK J. Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria. Microbiological Research, 2015,170:1-9. DOI:10.1016/j.micres.2014.09.006
doi: 10.1016/j.micres.2014.09.006
|
17 |
GERRITZEN M J H, STANGOWEZ L, DE WATERBEEMD B VAN, et al. Continuous production of Neisseria meningitidis outer membrane vesicles. Applied Microbiology Biotechnology, 2019,103(23/24):9401-9410. DOI:10.1007/s00253-019-10163-z
doi: 10.1007/s00253-019-10163-z
|
18 |
DEVIENNE K F, RADDI M S G. Screening for antimicrobial activity of natural products using a microplate photometer. Brazilian Journal of Microbiology, 2002,33(2):166-168. DOI:10.1590/S1517-83822002000200014
doi: 10.1590/S1517-83822002000200014
|
19 |
ALVES N J, TURNER K B, MEDINTZ I L, et al. Emerging therapeutic delivery capabilities and challenges utilizing enzyme/protein packaged bacterial vesicles. Therapeutic Delivery, 2015,6(7):873-887. DOI:10.4155/tde.15.40
doi: 10.4155/tde.15.40
|
20 |
GU L, MENG R, TANG Y T, et al. Toll-like receptor 4 signaling licenses the cytosolic transport of lipopolysaccharide from bacterial outer membrane vesicles. Shock, 2019,51(2):256-265. DOI:10.1097/SHK.0000000000001129
doi: 10.1097/SHK.0000000000001129
|
21 |
FINGERMANN M, AVILA L, DE MARCO M B, et al. OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves. Human Vaccines and Immunotherapeutics, 2018,14(9):2208-2213. DOI:10.1080/21645515.2018.1490381
doi: 10.1080/21645515.2018.1490381
|
22 |
ORMAZáBAL M, BARTEL E, GAILLARD M E, et al. Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles. Vaccine, 2014,32(46):6084-6090. DOI:10.1016/j.vaccine.2014.08.084
doi: 10.1016/j.vaccine.2014.08.084
|
23 |
KIM O Y, PARK H T, DINH N T H, et al. Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response. Nature Communications, 2017,8(1):626. DOI:10.1038/s41467-017-00729-8
doi: 10.1038/s41467-017-00729-8
|
24 |
LIU J, HSIEH C L, GELINCIK O, et al. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum. Journal of Proteomics, 2019,195:125-137. DOI:10.1016/j.jprot.2018.12.029
doi: 10.1016/j.jprot.2018.12.029
|
25 |
GUJRATI V, KIM S, KIM S H, et al. Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. ACS Nano, 2014,8(2):1525-1537. DOI:10.1021/nn405724x
doi: 10.1021/nn405724x
|
26 |
MATTOO S, CHERRY J D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clinical Microbiology Reviews, 2005,18(2):326-382. DOI:10.1128/CMR.18.2.326-382.2005
doi: 10.1128/CMR.18.2.326-382.2005
|
27 |
YOON H, ANSONG C, ADKINS J N, et al. Discovery of Salmonella virulence factors translocated via outer membrane vesicles to murine macrophages. Infection and Immunity, 2011,79(6):2182-2192. DOI:10.1128/CMR.18.2.326-382.2005
doi: 10.1128/CMR.18.2.326-382.2005
|
28 |
BOTTERO D, ZURITA M E, GAILLARD M E, et al. Membrane vesicles derived from Bordetella bronchiseptica: active constituent of a new vaccine against infections caused by this pathogen. Applied and Environmental Microbiology, 2018,84(4):e01877-17. DOI:10.1128/AEM.01877-17
doi: 10.1128/AEM.01877-17
|
29 |
LóPEZ-BOADO Y S, COBB L M, DEORA R. Bordetella bronchiseptica flagellin is a proinflammatory determinant for airway epithelial cells. Infection and Immunity, 2005,73(11):7525-7534. DOI:10.1128/IAI.73.11.7525-7534.2005
doi: 10.1128/IAI.73.11.7525-7534.2005
|
30 |
LIU Y, CHEN H, WEI Q, et al. Immune efficacy of five novel recombinant Bordetella bronchiseptica proteins. BMC Veterinary Research, 2015,11:173. DOI:10.1186/s12917-015-0488-4
doi: 10.1186/s12917-015-0488-4
|
31 |
ASENSIO C J, GAILLARD M E, MORENO G, et al. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate. Vaccine, 2011,29(8):1649-1656. DOI:10.1016/ j.vaccine.2010.12.068
doi: 10.1016/
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|